Home » Prices » NYSEAMERICAN:CVM

CEL-SCI Corporation NYSEAMERICAN:CVM

Today's live share price, quote history, chart & news

Price:
13.99 USD
Change:
-0.41 (-2.85%)
Key Stats
Price open 14.5
Previous close 14.4
Market cap 526.50M
Volume 558.77K
Day high 14.72
Day low 13.75
Year high 18
Year low 3.7
Year to date change 54.16%
P/E Ratio -15.39
Company Profile
Fundamentals
Insider Information
News

About CEL-SCI Corporation

CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Company information

Company name
CEL-SCI Corp.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
N.A
CEO
Geert R. Kersten
Address
8229 Boone Boulevard, Vienna, VA, 22182
Country
United States
Contact information
1.703.506.9460
Website
http://www.cel-sci.com

Related companies

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.